Short Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Declines By 21.3%

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 19,600 shares, a decrease of 21.3% from the October 31st total of 24,900 shares. Based on an average daily volume of 14,400 shares, the days-to-cover ratio is presently 1.4 days. Currently, 1.4% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. StockNews.com started coverage on Arcadia Biosciences in a research report on Sunday. They set a “sell” rating for the company. HC Wainwright reaffirmed a “buy” rating and issued a $6.00 target price on shares of Arcadia Biosciences in a report on Wednesday, August 21st.

Arcadia Biosciences Price Performance

Shares of RKDA stock traded up $0.03 during trading hours on Friday, reaching $2.79. The company had a trading volume of 14,014 shares, compared to its average volume of 11,308. The company has a 50 day moving average of $3.32 and a 200 day moving average of $3.07. Arcadia Biosciences has a 1-year low of $1.85 and a 1-year high of $5.34. The firm has a market cap of $3.79 million, a price-to-earnings ratio of -0.65 and a beta of 1.27.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.